Incanthera (AQSE:INC) Additional Paid-In Capital : £5.24 Mil(As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Additional Paid-In Capital?

Incanthera's quarterly additional paid-in capital increased from Sep. 2022 (£5.06 Mil) to Mar. 2023 (£5.17 Mil) and increased from Mar. 2023 (£5.17 Mil) to Sep. 2023 (£5.24 Mil).

Incanthera's annual additional paid-in capital stayed the same from Mar. 2021 (£5.06 Mil) to Mar. 2022 (£5.06 Mil) but then increased from Mar. 2022 (£5.06 Mil) to Mar. 2023 (£5.17 Mil).

Incanthera Additional Paid-In Capital Historical Data

The historical data trend for Incanthera's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Additional Paid-In Capital Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

4.44

5.06

5.17

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial			5.06	5.06	5.06	5.17	5.24

Incanthera Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Incanthera Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Incanthera's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines